“vlst” Archives

Entry Author Date Location
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
Thong Le Takes Over at Accelerator, With Eyes on Seattle and NYC 01/29/14 Seattle
VLST, After Nine Years and $50M, Sells Assets and Winds Down 08/07/13 Seattle
Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down 10/11/12 Seattle
VLST Cuts Scientific Group As Focus Shifts to Clinical Trials 09/27/12 Seattle
VLST Scoops Up Antibody for Cancer From Pfizer 08/31/12 Seattle
VLST Obtains $5,000,000 New Funding 06/15/12 Seattle
VLST Raises $5M To Carry on With Autoimmune R&D 06/14/12 Seattle
OVP, Looking for a Home Run, Hits Bunt Single With Complete Genomics 03/21/12 Seattle
Theraclone, VLST Founders Form New Antibody Startup, V-Gene 01/26/12 Seattle
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
Accelerator Reaches Out to East Coast to Find Latest Startup, Acylin Therapeutics 12/01/10 Seattle
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO 11/12/10 Seattle
Dendreon Makes History, Microsoft Tries Open-Source Biology, an OVP IPO Is Brewing, & More Seattle-Area Life Sciences News 05/06/10 Seattle
An OVP IPO is Brewing, Allozyne Doing Fine, VLST Finds Second Partner, & More Tidbits from the OVP Tech Summit 05/04/10 Seattle
Life Sciences Is Gaining on Software as a Job Creator & Other Notes from Zino Society Forum 04/27/10 Seattle
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash 04/26/10 Seattle
The Dendreon Alumni: Where Are They Now? 03/31/10 Seattle
Adaptive TCR, a Fred Hutch Spinoff, Nabs $4.5M to Uncover Immune System Secrets 03/26/10 Seattle
Biotech Bigwig, Steve Burrill, Brings National Profile to Local Conference 01/29/10 Seattle
Accelerator Slowed Down in 2009, Expects to Rev Back Up in 2010 01/27/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News 12/24/09 Seattle
VLST Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk Pipeline 12/22/09 Seattle
The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday 10/15/09 Seattle
From Academics to Biotech: A Journey to the Supposed “Dark Side” 09/28/09 Seattle
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 2) 09/24/09 Seattle
Page 1 of 2 next page »